tweenvest

KRM Ayurveda Limited (NSEI: KRMAYURVED)

Health Care · Pharmaceuticals · IN

Rs229.90

-4.86% today · +27.2% 1Y

Public summary
A free snapshot of KRM Ayurveda Limited, with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

KRM Ayurveda Limited (NSEI: KRMAYURVED) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $51.99M.

Over the last twelve months the share price has gained 27.2%, trading between 156.15 and 343.95.

Tweenvest scores KRM Ayurveda Limited across four factors: quality 82/100, value 75/100. Its strongest factor is quality.

KRMAYURVED price history

Feb 1, 2026 · 168.95Weekly closes 168.95 – 312.20Nov 13, 2026 · 229.90

Key figures

Market cap
$51.99M
Revenue (TTM)
$11.56M
P/E
20.87
EPS
9.46
Dividend yield
—
Beta (5Y)
—
52-week high
Rs343.95
52-week low
Rs156.15
Avg volume (3M)
—
Shares outstanding
21.26M
Employees
—
Next earnings
—
CompanyMarket capPriceDay
Eloxx Pharmaceuticals, Inc.NasdaqCM: ELOX$53.08M$13.15+2.02%
Cinclus Pharma Holding AB (publ)OM: CINPHA$53.06MSkr11.52-0.52%
Haleos Labs LimitedNSEI: HALEOSLABS$52.96MRs1,636.80+1.10%
Citi Pharma LimitedKASE: CPHL$52.39MPKRs63.42-0.20%
Daehan Nupharm Co.,Ltd.KOSDAQ: A054670$51.76M₩4,930.00-1.99%
AB Science S.A.ENXTPA: AB$51.52M€0.59-6.40%
Enzychem Lifesciences CorporationKOSDAQ: A183490$51.50M₩990.00-2.65%
Chi Sheng Pharma & Biotech Co., LtdTPEX: 4111$51.48MNT$28.350.00%

Browse every Pharmaceuticals company →